Related Experiment Video
Updated: May 24, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Heart rate recovery after exercise and long-term prognosis in patients with coronary artery disease
Mathieu Gayda1, Martial G Bourassa, Jean-Claude Tardif
1Montreal Heart Institute Cardiovascular and Prevention Centre (Centre ÉPIC), Montreal, Québec, Canada.
Insights
Heart rate recovery (HRR) after exercise predicts long-term survival in stable coronary artery disease (CAD) patients. Lower HRR indicates higher mortality risk, making it a valuable prognostic tool.
Area of Science:
- Cardiology
- Clinical Outcomes Research
- Preventive Cardiology
Background:
- The prognostic significance of heart rate recovery (HRR) in coronary artery disease (CAD) patients requires further elucidation.
- Previous studies have provided limited long-term data on HRR's predictive value in this population.
Purpose of the Study:
- To confirm the prognostic value of HRR in a large cohort of patients with stable CAD.
- To investigate the association between HRR and long-term mortality outcomes.
Main Methods:
- Utilized data from 4097 patients with CAD from the Coronary Artery Surgery Study registry.
- Measured HRR at 3 minutes post-exercise during passive recovery.
- Analyzed clinical outcomes using threshold and continuous models based on HRR.
Main Results:
- A heart rate recovery (HRR) below 46 beats per minute (Bpm) was associated with increased all-cause death risk.
- Each 10 Bpm increase in HRR correlated with a reduced risk of all-cause and cardiovascular mortality.
- Long-term follow-up averaged 14.7 years.
Conclusions:
- Three-minute HRR independently predicts long-term all-cause and cardiovascular mortality in stable CAD.
- HRR measurement serves as a complementary tool for identifying high-risk patients.
Background:
The long-term prognostic value of heart rate recovery (HRR) has been incompletely documented in patients with coronary artery disease (CAD). We sought to confirm the prognostic value of HRR in a large cohort with stable CAD.
Methods:
From the Coronary Artery Surgery Study registry, a database of 24,958 patients with CAD who underwent cardiac catheterization between 1974 and 1979, we identified 4097 patients with baseline exercise stress testing data. HRR was measured at 3 minutes post exercise during a passive recovery. Clinical outcomes were evaluated according to HRR in both threshold and continuous models.
Results:
Median long-term follow-up was 14.7 years (interquartile range, 9.8-16.2). HRR < 46 beats per minute (Bpm) most appropriately differentiated nonsurvivors from survivors (area under receiver operating characteristic curve = 0.613) and was associated with an increased risk of all-cause death (adjusted hazard ratio = 1.15; P = 0.011). Increasing HRR was associated with a lower risk of all-cause (adjusted hazard ratio = 0.94 per 10 Bpm; 95% confidence interval, 0.91-0.97; P = 0.0005) and cardiovascular (CV) mortality (adjusted hazard ratio = 0.94 per 10 Bpm; 95% confidence interval, 0.90-0.98; P = 0.003).
Conclusions:
HRR at 3 minutes independently predicts long-term all-cause and CV mortality in patients with stable CAD. Measurement of HRR at 3 minutes during passive recovery can be used as a complementary tool to identify patients with a higher total and CV risk.
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be met...
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
